K

Newpath Partners logo

Newpath Partners

Crunchbase
Pitchbook

Deals on record

4

Common Fundraising Type

Equity

nChroma Bio logo
nChroma Bio

Epigenetic editing • Genetic medicines

Wilson Sonsini Goodrich & Rosati logo
Wellington Management logo
T. Rowe Price logo
Sofinnova Partners logo

nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.

Equity
$75M
12/11/2024
Article
Metsera logo
Metsera

Biopharmaceutical • Clinical-stage

Venrock logo
Wellington Management logo
T. Rowe Price logo
SymBiosis logo

Metsera is a clinical-stage biopharmaceutical company developing next-generation treatments for obesity and metabolic diseases using their innovative platforms and Nutrient-Stimulated Hormone analog peptides.

Series B
$215M
11/13/2024
Article
Leal Therapeutics logo
Leal Therapeutics

Biotechnology • Central Nervous System

Chugai Venture Fund logo
Newpath Partners logo
PhiFund logo
OrbiMed logo

Leal Therapeutics is a biotechnology company developing treatments for central nervous system disorders, focusing on amyotrophic lateral sclerosis (ALS) and schizophrenia.

Equity
$45M
10/30/2024
Article
Magnet Biomedicine logo
Magnet Biomedicine

Biotechnology • Drug Discovery

Newpath Partners logo
ARCH Venture Partners logo

Magnet Biomedicine is a biotechnology company that develops TrueGlues compounds to induce cooperative protein-protein interactions, aiming to optimize therapeutic impact and address undruggable proteins in areas such as cancer, cardiovascular disease, and immune disorders.

Equity
$50M
09/19/2023
Article